Peripheral Embolization Coils Market is expected to reach US$ 613.96 Million by 2031

Detachable Coils Segment to Contribute Significantly to Peripheral Embolization Coils Market Growth During 2023–2031 

According to our latest study on "Peripheral Embolization Coils Market Forecast to 2031 – Global Analysis – Type, Material, and Application," the market was valued at US$ 433.06 million in 2023 and is projected to reach US$ 613.96 million by 2031. Factors such as a rise in the prevalence of aortic aneurysm and an increase in the incidence of cancer are the key factors contributing to the growing peripheral embolization coils market size. However, complications arising during or after embolization impede the peripheral embolization coils market growth.

Peripheral embolization coil manufacturers understand the importance of packing density and have started implementing numerous ways to help accomplish it. Focusing specifically on packing density allows them to limit thrombus development and, presumably, the danger of recanalization. Packing density, determined more by the volume of coils than the volume of the thrombus, is the number of coils required to cause an occlusion. Bare-metal coils such as the Ruby coils and Prestige Plus peripheral coil systems are softer than fibered coils, resulting in a high packing density within the target vascular space. The use of hydrogel in coil design and production is another technique that is employed to increase packing density. The hydrogel layered on the coil surface is a bioactive polymer that undergoes swelling after it comes in contact with blood, increasing the coils' filling volume upon deployment in the target vessel. This volume provided by hydrogel presents a greater proportion of the blockage made by metal coil loops and hydrogel rather than thrombus, which has been linked to lower rates of vascular recanalization. Thus, the surging importance of packaging density is likely to emerge as a significant peripheral embolization coils market trend in the future.

Peripheral Embolization Coils Market, by Region, 2023 (%)

Source: The Insight Partners Analysis

Market Segmentation:

The peripheral embolization coils market analysis has been carried out by considering the following segments: type, material, and application. Based on type, the market is bifurcated into pushable coil and detachable coil. The detachable coils segment held a larger peripheral embolization coils market share in 2023, and it is anticipated to register a higher CAGR during 2023–2031. Detachable embolization coils are used for venous and arterial embolization in the peripheral vasculature. The coils are available in several rigidity, size, and shape specifications, and catheter compatibilities, among others, which render them suitable for various functions. The coils, generally made up of platinum, are placed with one-click mechanical detachment handle technology. Detachable coils are most useful for intracranial interventions or in conditions with an elevated risk of coil migration due to high vascular flow; they can be recaptured and repositioned several times before release, allowing more precise placement. Some detachable coils are released when pressure or electrolysis tampers the weld. For instance, in GDC Detachable Coils (Cook Medical) and Matrix Detachable Coils (Boston Scientific), the connection between the coil and the delivery wire dissolves when the operator applies a current to the delivery wire.

By material, the peripheral embolization coils market is divided into platinum, platinum and hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023, and it is anticipated to register the highest CAGR during 2023–2031. Platinum coils are deposited into the aneurysm to block blood flow to the aneurysm, thereby preventing its rupture. These coils are visible via X-ray detection as they are extremely radio-opaque. They are adjustable and flexible enough to fit the shape of the aneurysm. The most frequently used platinum-based peripheral embolization coil profiles are 0.035-, 0.038-, and 0.018-inch microcoils. They are offered in the length range of 1–300 mm and the diameters range of 1–27 mm in linear, helical, spiral, or other complicated 3D structures. Platinum coils with synthetic fibers are used to embolize selective vascular supply to arteriovenous malformations. The growth of the peripheral embolization coils market for the platinum segment is attributed to the thrombogenicity, softness, and flexibility of coils in surgical procedures, among other advantages of platinum-based microcoil systems.

By application, the peripheral embolization coils market is divided into bleedings and trauma, malformations, tumors, visceral aneurysms, endoleak type II, and varicose veins. The bleeding and trauma segment held the largest market share in 2023, and it is anticipated to register the highest CAGR during 2023–2031. Trauma has been a leading cause of death in the young population. According to an article published in BMC Public Health, uncontrolled bleeding following trauma accounts for 30–40% of the total trauma-related mortality recorded across the world. The most commonly used coils for embolization in patients suffering from trauma are microcoils with sizes ranging from 0.038 inch to 0.035 inch and diameters ranging from 3 mm to 15 mm. Coils can be deployed through catheters by pushing, injecting, or detaching them, with the method of detachment providing more control at the embolic site.

Peripheral Embolization Coils Market, by Geography:

The scope of the peripheral embolization coils market report entails North America (US, Canada, and Mexico), Europe (UK, Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of APAC), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). 

In terms of revenue, Europe dominated the peripheral embolization coils market in 2023. North America is expected to witness growth during the forecast period owing to factors such as an upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. Colorectal cancer is the fourth most prevalent cancer in Mexico, with most cases reported after the age of 50, with a comparable distribution of cases in both genders. As a result, the number of new cases and rate of mortality have steadily climbed alongside the rising life expectancy. Cancer incidences are rising in Mexico, and colorectal cancer is ranked as the third most frequently diagnosed cancer. According to the IMSS, approximately 15,000 new cases are registered with colon cancer in the country every year. The market for colorectal cancer in Mexico is expected to grow to increase the campaign for early detection of cancers. According to GLOBOCAN, in Mexico, the incidence rate of gastric cancer was 6.2% in 2020, with a mortality rate of 4.7 per 100,000 persons. Microcoil embolization is a well-established treatment for upper gastrointestinal bleeding that can be performed closer to the bleeding site. The procedure performed using a superselective catheter is a safe and effective way of managing acute lower gastrointestinal bleeding.

Apart from factors driving the market, the peripheral embolization coils market report emphasizes on prominent players operating in the market; these include Medtronic Plc, Penumbra Inc., Balt, Boston Scientific Corp, Cook Medical Holdings LLC, Wallaby Medical, Spartan Micro Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD., Terumo Corp, and NeuroSafe Medical Co. Ltd.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com